Better Growth Stock: Kinaxis Inc. or Jamieson Wellness Inc.?

Kinaxis Inc. (TSX:KXS) and Jamieson Wellness Inc. (TSX:JWEL) released fourth-quarter and full-year results in late February.

| More on:
The Motley Fool

Indexes in the United States and Canada were pummeled again on March 1. Markets continued to react negatively to comments from U.S. Federal Reserve chairman Jerome Powell and the promise of more interest rate hikes. President Trump also rattled markets after announcing that the U.S. would unveil tariffs on steel and aluminum imports next week. Whether or not this will exclude key allies like Canada is yet to be determined as of March 1.

Investors are understandably rattled, as this aging bull market is starting to wobble. However, there are still opportunities available for investors looking for long-term options. Today we will compare two top growth stocks on the TSX.

Kinaxis Inc. (TSX:KXS)

Kinaxis is an Ottawa-based software company that offers supply chain solutions to its client base. Shares of Kinaxis have climbed 9.7% in 2018. However, the stock dropped 3% on March 1 on the same day it announced its 2017 fourth-quarter and full-year results.

Kinaxis leadership trumpeted its latest contract win in the form of Toyota Motor Corp., the second-largest automobile manufacturer in the world. In the fourth quarter, Kinaxis saw revenue and subscription revenue rise 14% and 19%, respectively. Profit soared 221% year over year to $5.5 million, or $0.21 per diluted share.

For the full year, Kinaxis reported that revenue increased 15% to $133.3 million. Profit rose 90% to $20.4 million, or $0.77 per diluted share, and adjusted EBITDA jumped 40% to $40.1 million — 30% of total revenue. Cash from operating activities also rose 8% to $33.6 million. CEO John Sicard announced that Kinaxis would look to expand its global operations in Europe and Asia in response to its positive results.

Jamieson Wellness Inc. (TSX:JWEL)

Jamieson is a manufacturer, distributor, and marketer of sports nutrition products and supplements. Jamieson stock has dropped 6.4% in 2018 thus far but rose 1.46% on March 1. The company released its 2017 fourth-quarter and full-year results on February 22.

In the fourth quarter, revenue rose 28.3% to $84.3 million, and adjusted net income surged 91.1% year over year to $9.7 million. Adjusted EBITDA increase 28% to $18.8 million. The increase in revenue was buoyed by the acquisition of Body Plus and a jump in domestic volumes for Jamieson products.

For the full year, Jamieson saw revenue rise 21.1% to $300.6 million and reported a 152.8% increase in adjusted net income to $27.6 million. Adjusted EBITDA also climbed 31.4% to $61.5 million. For 2018 Jamieson leadership has projected revenue in a range of $325-335 million and adjusted EBITDA in a range of $67-69 million. Jamieson also announced a quarterly dividend of $0.08 per share, representing a 1.5% dividend yield.

Which is the better buy?

Both companies appear poised to post solid growth going forward. Kinaxis has been an explosive growth stock since debuting in 2014, rising over 550% since its initial public offering. Its forays into Europe and Asia have yielded early success, and investors may want to stack if shares tumble in a shaky market. For investors on the lookout for a little bit more income in their portfolios, Jamieson is also rock solid and well positioned to benefit from aging demographics.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. Kinaxis is a recommendation of Stock Advisor Canada.

More on Investing

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Arrowings ascending on a chalkboard
Energy Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Canadian Natural Resources stock is well set up to beat the TSX as it continues to generate strong cash flows…

Read more »

think thought consider
Dividend Stocks

Down 10.88%: Is ATD Stock a Good Buy After Earnings?

Alimentation Couche-Tard (TSX:ATD) stock might not be the easy buy-case it once was. Here’s a look at what happened.

Read more »

money cash dividends
Dividend Stocks

TFSA Dividend Stocks: Earn $1,200/Year Tax-Free

Canadian stocks like Fortis are a must-have in your portfolio to earn tax-free yields for decades.

Read more »